NIOX Group (NIOX) Competitors GBX 65.20 +0.20 (+0.31%) (As of 12:20 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades NIOX vs. MXCT, EKF, CREO, IUG, NCYT, POLX, BELL, IHC, AVO, and RUAShould you be buying NIOX Group stock or one of its competitors? The main competitors of NIOX Group include MaxCyte (MXCT), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Polarean Imaging (POLX), Belluscura (BELL), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), and RUA Life Sciences (RUA). These companies are all part of the "medical devices" industry. NIOX Group vs. MaxCyte EKF Diagnostics Creo Medical Group Intelligent Ultrasound Group Novacyt Polarean Imaging Belluscura Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MaxCyte (LON:MXCT) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment. Which has more risk and volatility, MXCT or NIOX? MaxCyte has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Is MXCT or NIOX more profitable? NIOX Group has a net margin of 30.00% compared to MaxCyte's net margin of -77.97%. NIOX Group's return on equity of 13.52% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets MaxCyte-77.97% -15.33% -11.07% NIOX Group 30.00%13.52%3.95% Does the MarketBeat Community believe in MXCT or NIOX? MaxCyte received 152 more outperform votes than NIOX Group when rated by MarketBeat users. However, 100.00% of users gave NIOX Group an outperform vote while only 68.92% of users gave MaxCyte an outperform vote. CompanyUnderperformOutperformMaxCyteOutperform Votes15368.92% Underperform Votes6931.08% NIOX GroupOutperform Votes1100.00% Underperform VotesNo Votes Which has preferable earnings and valuation, MXCT or NIOX? NIOX Group has lower revenue, but higher earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxCyte£45.44M6.15-£35.43M-£0.26-1,023.08NIOX Group£39M7.09£11M£0.023,260.00 Does the media refer more to MXCT or NIOX? In the previous week, NIOX Group had 2 more articles in the media than MaxCyte. MarketBeat recorded 3 mentions for NIOX Group and 1 mentions for MaxCyte. NIOX Group's average media sentiment score of 0.37 beat MaxCyte's score of 0.00 indicating that NIOX Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MaxCyte 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NIOX Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in MXCT or NIOX? 70.5% of MaxCyte shares are owned by institutional investors. Comparatively, 35.2% of NIOX Group shares are owned by institutional investors. 1.5% of MaxCyte shares are owned by insiders. Comparatively, 46.7% of NIOX Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryNIOX Group beats MaxCyte on 11 of the 15 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get NIOX Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIOX vs. The Competition Export to ExcelMetricNIOX GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£276.53M£2.04B£5.10B£1.40BDividend Yield1.52%2.49%5.04%11.79%P/E Ratio3,260.00212.3295.121,555.80Price / Sales7.09202.001,217.30210,506.32Price / Cash11.2116.0539.4933.06Price / Book3.433.356.972.81Net Income£11M£70.94M£118.73M£153.14M7 Day Performance1.56%-2.27%-1.22%-0.48%1 Month Performance-0.61%-2.32%-3.07%7.21%1 Year Performance4.49%26.00%32.52%93.59% NIOX Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIOXNIOX GroupN/AGBX 65.20+0.3%N/A+0.0%£276.53M£39M3,260.0092MXCTMaxCyteN/AGBX 266+1.5%N/A-22.4%£279.54M£45.44M-1,026.9280News CoverageGap UpHigh Trading VolumeEKFEKF DiagnosticsN/AGBX 25.20-2.9%N/A-7.1%£114.34M£50.95M2,595.00356Positive NewsCREOCreo Medical GroupN/AGBX 16.12-0.8%N/A-50.4%£58.33M£30.30M-270.83279IUGIntelligent Ultrasound GroupN/AGBX 11.55-0.6%N/A+18.6%£37.77M£9.88M-1,162.5065High Trading VolumeNCYTNovacytN/AGBX 47.94-2.6%N/A-7.9%£33.86M£18.56M-92.31120POLXPolarean ImagingN/AGBX 1.55+1.6%N/A-78.3%£18.76M£1.87M-81.0028Gap UpBELLBelluscuraN/AGBX 9.50-5.0%N/A-58.0%£16.00M£1.80M-100.7524Gap DownIHCInspiration Healthcare GroupN/AGBX 15.65-0.6%N/A-60.5%£14.03M£34.30M-112.50224Positive NewsAVOAdvanced OncotherapyN/AGBX 1.75-9.1%N/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.30-3.8%N/A-46.9%£7.01M£2.19M-293.7548 Related Companies and Tools Related Companies MaxCyte Alternatives EKF Diagnostics Alternatives Creo Medical Group Alternatives Intelligent Ultrasound Group Alternatives Novacyt Alternatives Polarean Imaging Alternatives Belluscura Alternatives Inspiration Healthcare Group Alternatives Advanced Oncotherapy Alternatives RUA Life Sciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:NIOX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NIOX Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share NIOX Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
